| Tracey L Siebold, M,S, CCC/SLP, CED | |
|
4202 Hermosa Dr, Corpus Christi, TX 78411-4535 | |
| (361) 728-9192 | |
| (361) 334-1136 |
| Full Name | Tracey L Siebold |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4202 Hermosa Dr, Corpus Christi, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023294824 | NPI | - | NPPES |
| 1023294824 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 19676 (Texas) | Primary |
| Provider Name | A Place For Speech |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366957987 PECOS PAC ID: 8426319112 Enrollment ID: O20180220001755 |
News Archive
Aria Diagnostics, a molecular diagnostics company, announced that it is initiating a blinded, multicenter clinical trial that compares its non-invasive prenatal test with the standard first-trimester screening test (serum screening and nuchal translucency ultrasound alone and in combination) to detect Trisomy 21, which is associated with Down syndrome.
In the United States Clostridium difficile or "C. difficile" is now recognized as one of the most dangerous and fastest growing Healthcare Acquired Infections (HAIs) in existence. Now surpassing even Staphylococcus aureus (MRSA), C. difficile infections tripled between 2000 and 2005.
People with memory problems who are depressed are more likely to develop Alzheimer's disease compared to people who are not depressed, according to a study published in the June 16, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology. However, the research also shows that the popular Alzheimer's drug donepezil may delay the progression to Alzheimer's disease for depressed people with mild cognitive impairment (MCI) or memory problems.
Kaydon Corporation today announced that it has completed the acquisition of all of the outstanding shares of HAHN-Gasfedern GmbH and related real estate and intangible property ("Hahn") from Ulrich Hahn e.K. pursuant to the definitive agreement announced on February 25, 2011.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study to include clinical trial sites in Japan.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tracey L Siebold, M,S, CCC/SLP, CED Po Box 271416, Corpus Christi, TX 78427-1416 Ph: (361) 334-1136 | Tracey L Siebold, M,S, CCC/SLP, CED 4202 Hermosa Dr, Corpus Christi, TX 78411-4535 Ph: (361) 728-9192 |
News Archive
Aria Diagnostics, a molecular diagnostics company, announced that it is initiating a blinded, multicenter clinical trial that compares its non-invasive prenatal test with the standard first-trimester screening test (serum screening and nuchal translucency ultrasound alone and in combination) to detect Trisomy 21, which is associated with Down syndrome.
In the United States Clostridium difficile or "C. difficile" is now recognized as one of the most dangerous and fastest growing Healthcare Acquired Infections (HAIs) in existence. Now surpassing even Staphylococcus aureus (MRSA), C. difficile infections tripled between 2000 and 2005.
People with memory problems who are depressed are more likely to develop Alzheimer's disease compared to people who are not depressed, according to a study published in the June 16, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology. However, the research also shows that the popular Alzheimer's drug donepezil may delay the progression to Alzheimer's disease for depressed people with mild cognitive impairment (MCI) or memory problems.
Kaydon Corporation today announced that it has completed the acquisition of all of the outstanding shares of HAHN-Gasfedern GmbH and related real estate and intangible property ("Hahn") from Ulrich Hahn e.K. pursuant to the definitive agreement announced on February 25, 2011.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study to include clinical trial sites in Japan.
› Verified 2 days ago
Mrs. Kelley Cook Mailhes, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Louisiana Ave, Corpus Christi, TX 78404 Phone: 361-853-0488 Fax: 361-843-0489 | |
Amanda Marie Philen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2505 Waldron Rd, Corpus Christi, TX 78418 Phone: 361-694-9650 | |
Sarah Kathyrn Rodriguez, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3533 S Alameda St, Corpus Christi, TX 78411 Phone: 631-694-5000 | |
Terri L Sutphin, M.S.,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Louisiana Ave. , Ste #402, Corpus Christi, TX 78404 Phone: 361-853-0488 | |
Sarah Courtney Gleinser, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3533 S Alameda St, Corpus Christi, TX 78411 Phone: 631-694-5000 | |
Karen Scot Ferguson, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7102 Taos Dr, Corpus Christi, TX 78413 Phone: 361-808-7747 |